International Biotechnology Trust as of Sept. 30, 2018
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 51 positions in its portfolio as reported in the September 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 8.3 | $17M | 254k | 68.63 | |
Illumina (ILMN) | 6.9 | $15M | 52k | 281.43 | |
Incyte Corporation (INCY) | 5.0 | $11M | 200k | 52.96 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 4.8 | $10M | 68k | 147.80 | |
Array BioPharma | 4.7 | $9.8M | 845k | 11.66 | |
Regeneron Pharmaceuticals (REGN) | 4.6 | $9.7M | 31k | 309.83 | |
Exelixis (EXEL) | 4.5 | $9.6M | 705k | 13.59 | |
Alexion Pharmaceuticals | 4.1 | $8.7M | 82k | 106.56 | |
D Stemline Therapeutics | 3.5 | $7.5M | 586k | 12.73 | |
Ligand Pharmaceuticals In (LGND) | 3.5 | $7.4M | 35k | 210.37 | |
BioMarin Pharmaceutical (BMRN) | 3.4 | $7.2M | 97k | 74.36 | |
Halozyme Therapeutics (HALO) | 2.8 | $6.0M | 429k | 13.93 | |
Aerie Pharmaceuticals | 2.8 | $5.9M | 125k | 47.20 | |
Adamas Pharmaceuticals | 2.7 | $5.7M | 370k | 15.33 | |
Kalvista Pharmaceuticals (KALV) | 2.6 | $5.5M | 322k | 16.96 | |
Gilead Sciences (GILD) | 2.5 | $5.3M | 90k | 59.21 | |
Puma Biotechnology (PBYI) | 2.4 | $5.1M | 144k | 35.16 | |
Abiomed | 2.2 | $4.6M | 13k | 344.92 | |
Zogenix | 2.0 | $4.2M | 110k | 38.04 | |
Spectrum Pharmaceuticals | 1.8 | $3.9M | 300k | 12.88 | |
Alnylam Pharmaceuticals (ALNY) | 1.7 | $3.5M | 53k | 67.10 | |
Shire | 1.6 | $3.5M | 25k | 139.00 | |
Neurocrine Biosciences (NBIX) | 1.6 | $3.3M | 36k | 94.31 | |
Sarepta Therapeutics (SRPT) | 1.6 | $3.3M | 27k | 123.85 | |
G1 Therapeutics (GTHX) | 1.4 | $2.9M | 72k | 40.06 | |
Jazz Pharmaceuticals (JAZZ) | 1.3 | $2.8M | 22k | 128.94 | |
Seattle Genetics | 1.2 | $2.5M | 43k | 59.13 | |
Intersect Ent | 1.2 | $2.5M | 112k | 22.04 | |
Deciphera Pharmaceuticals (DCPH) | 1.1 | $2.3M | 77k | 29.69 | |
Agios Pharmaceuticals (AGIO) | 1.0 | $2.2M | 37k | 59.15 | |
Ionis Pharmaceuticals (IONS) | 1.0 | $2.0M | 52k | 39.55 | |
Bluebird Bio (BLUE) | 0.9 | $1.9M | 17k | 111.94 | |
Sage Therapeutics (SAGE) | 0.8 | $1.7M | 16k | 108.28 | |
Sutro Biopharma (STRO) | 0.8 | $1.7M | 147k | 11.50 | |
Madrigal Pharmaceuticals (MDGL) | 0.8 | $1.6M | 10k | 164.10 | |
Sangamo Biosciences (SGMO) | 0.7 | $1.5M | 113k | 12.96 | |
Fibrogen (FGEN) | 0.7 | $1.5M | 31k | 46.62 | |
Globus Med Inc cl a (GMED) | 0.6 | $1.3M | 29k | 43.52 | |
Gw Pharmaceuticals Plc ads | 0.6 | $1.3M | 9.6k | 132.50 | |
Cymabay Therapeutics (CBAY) | 0.6 | $1.2M | 145k | 8.49 | |
Merus N V (MRUS) | 0.5 | $1.1M | 75k | 15.13 | |
ACADIA Pharmaceuticals (ACAD) | 0.5 | $1.0M | 65k | 15.92 | |
Horizon Pharma | 0.5 | $1.0M | 69k | 15.01 | |
Supernus Pharmaceuticals (SUPN) | 0.4 | $809k | 21k | 38.61 | |
Paratek Pharmaceuticals | 0.4 | $766k | 104k | 7.40 | |
Corvus Pharmaceuticals (CRVS) | 0.3 | $710k | 108k | 6.57 | |
Spring Bk Pharmaceuticals In | 0.3 | $673k | 73k | 9.22 | |
Amicus Therapeutics (FOLD) | 0.3 | $543k | 59k | 9.27 | |
Spark Therapeutics | 0.2 | $502k | 12k | 41.83 | |
Radius Health | 0.1 | $257k | 19k | 13.67 | |
Enteromedics | 0.0 | $2.1k | 53k | 0.04 |